Gilead Sciences Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Dan O'Day

Chief executive officer

US$21.6m

Total compensation

CEO salary percentage7.8%
CEO tenure5yrs
CEO ownership0.04%
Management average tenure4.1yrs
Board average tenure6.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Dan O'Day's remuneration changed compared to Gilead Sciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

US$6b

Sep 30 2023n/an/a

US$6b

Jun 30 2023n/an/a

US$5b

Mar 31 2023n/an/a

US$6b

Dec 31 2022US$22mUS$2m

US$5b

Sep 30 2022n/an/a

US$3b

Jun 30 2022n/an/a

US$4b

Mar 31 2022n/an/a

US$5b

Dec 31 2021US$19mUS$2m

US$6b

Sep 30 2021n/an/a

US$7b

Jun 30 2021n/an/a

US$5b

Mar 31 2021n/an/a

US$301m

Dec 31 2020US$19mUS$2m

US$123m

Sep 30 2020n/an/a

US$1b

Jun 30 2020n/an/a

-US$257m

Mar 31 2020n/an/a

US$5b

Dec 31 2019US$29mUS$1m

US$5b

Compensation vs Market: Dan's total compensation ($USD21.62M) is above average for companies of similar size in the AR market ($USD5.56M).

Compensation vs Earnings: Dan's compensation has been consistent with company performance over the past year.


CEO

Dan O'Day (59 yo)

5yrs

Tenure

US$21,621,253

Compensation

Mr. Daniel P. O'Day, also known as Dan, serves as Non-Executive Non-Independent Director for Galapagos NV since October 22, 2019. He served as Member of Supervisory Board at Galapagos NV since October 22,...


Leadership Team

NamePositionTenureCompensationOwnership
Daniel P. O'Day
Chairman & CEO5yrsUS$21.62m0.039%
$ 30.1b
Andrew Dickinson
Executive VP & CFO4.3yrsUS$8.40m0.011%
$ 8.4b
Deborah Telman
Executive VP of Corporate Affairs1.6yrsUS$4.82m0.0011%
$ 850.5m
Johanna Mercier
Chief Commercial Officer4.7yrsUS$9.24m0.0095%
$ 7.4b
Merdad Parsey
Chief Medical Officer4.3yrsUS$9.04m0.0079%
$ 6.1b
Sandra Patterson
Senior VPless than a yearno data0.0026%
$ 2.0b
Jacquie Ross
Vice President of Investor Relations3.2yrsno datano data
Jyoti Mehra
Executive Vice President of Human Resources4.6yrsno datano data
Linda Higgins
Senior Vice President of Research4.1yrsno datano data
Rudolf Ertl
Senior Vice President of Commercial Operations of Australiano datano datano data
Flavius Martin
Executive Vice President of Research2.9yrsno datano data
William Grossman
Senior Vice President & Therapeutic Area Head of Gilead Oncology2.7yrsno datano data

4.1yrs

Average Tenure

57yo

Average Age

Experienced Management: GILD's management team is considered experienced (4.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Daniel P. O'Day
Chairman & CEO5yrsUS$21.62m0.039%
$ 30.1b
Anthony Welters
Independent Director3.4yrsUS$429.93k0.00064%
$ 494.8m
Paul Berg
Member of Scientific Advisory Boardno dataUS$16.00kno data
Jacqueline Barton
Independent Director6.2yrsUS$414.88k0.0018%
$ 1.4b
Eugene Schiff
Member of the Scientific Advisory Boardno datano datano data
Robert Schooley
Member of the Scientific Advisory Boardno datano datano data
John Mellors
Member of the Scientific Advisory Boardno datano datano data
Francis Chisari
Member of the Scientific Advisory Boardno datano datano data
Paul Klotman
Member of the Scientific Advisory Boardno datano datano data
Kevin Lofton
Lead Independent Director14.7yrsUS$489.93k0.0074%
$ 5.8b
Kelly Kramer
Independent Director7.6yrsUS$434.93k0.00011%
$ 85.0m
Joel Huff
Chairperson of Scientific Advisory Boardno datano datano data

6.2yrs

Average Tenure

68yo

Average Age

Experienced Board: GILD's board of directors are considered experienced (6.2 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.